Washington Trust Advisors’s Structure Therapeutics GPCR Stock Holding History

Washington Trust Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-41	Closed	-$1.15K	–	626
2025 Q3	$1.15K	Hold	41	–	–	﹤0.01%	677
2025 Q2	$850	Hold	41	–	–	﹤0.01%	627
2025 Q1	$710	Hold	41	–	–	﹤0.01%	632
2024 Q4	$1.11K	Hold	41	–	–	﹤0.01%	637
2024 Q3	$1.8K	Hold	41	–	–	﹤0.01%	641
2024 Q2	$1.61K	Hold	41	–	–	﹤0.01%	638
2024 Q1	$1.76K	Hold	41	–	–	﹤0.01%	642
2023 Q4	$1.67K	Buy	+41	New	+$2.35K	﹤0.01%	647

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Washington Trust Advisors's GPCR Position: Q4 2025 in Review

Washington Trust Advisors sold out of Structure Therapeutics (GPCR) in Q4 2025, closing a stake of 41 shares — an estimated $1.15K sold.

Washington Trust Advisors first reported a position in GPCR in Q4 2023 and held it in 8 quarters. The position peaked at $1.8K in Q3 2024. 197 funds tracked by Wall St. Rank hold GPCR as of Q4 2025.

Washington Trust Advisors reported no remaining Structure Therapeutics position as of Q4 2025 after selling out during the quarter.
Washington Trust Advisors sold 41 Structure Therapeutics shares in Q4 2025, an estimated $1.15K.
Washington Trust Advisors first reported a position in Structure Therapeutics in Q4 2023 and held it in 8 quarters.
Washington Trust Advisors's Structure Therapeutics position peaked at $1.8K in Q3 2024.
197 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.